165 filings
8-K
TRAW
Traws Pharma Inc.
16 Apr 24
Potential best in class p roduct candidates in development for cancer & respiratory viral diseases April 2024 NASDAQ - TRAW
4:06pm
8-K
TRAW
Traws Pharma Inc.
14 Nov 23
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
4:30pm
8-K
TRAW
Traws Pharma Inc.
29 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
TRAW
Traws Pharma Inc.
15 Aug 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
TRAW
Traws Pharma Inc.
10 Aug 23
Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
5:18pm
8-K
c8t mkxspibw
21 Jul 23
Other Events
4:45pm
8-K
ivc 5h1ke
15 May 23
Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
5:19pm
8-K
a0jyxabk
9 May 23
Other Events
8:35am
8-K
3r3wzd8nd
6 Apr 23
Onconova Therapeutics Announces the Unexpected Passing of Chief Medical Officer Dr. Mark Gelder
5:13pm
8-K
bhqwk46n8x mz
16 Mar 23
Onconova Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update
5:01pm
8-K
ljcl8 8nsaaxry
13 Feb 23
Other Events
5:22pm
8-K
2i5hcn5
19 Dec 22
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors
5:09pm
8-K
rgugnp9u y6j9kpf8
14 Nov 22
Initiation of Phase 1/2a endometrial cancer trial expected in 1Q23; preliminary data expected 4Q23
4:20pm
8-K
71t0skns8x58u abiw
18 Aug 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
kr0njxhv4prhpylzuh
11 Aug 22
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
5:25pm
8-K
0r5wm4s
21 Jul 22
Other Events
4:32pm
8-K
qf80 hv2zto5q4w7td
13 Jun 22
Onconova Therapeutics Announces Key Management Promotions
8:05am
8-K
m3c7nx
11 May 22
Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
4:07pm
8-K
d9hxn3dzmrid9uj8euyj
17 Mar 22
Onconova Therapeutics Reports Full Year 2021 Financial Results and Provides Business Update
4:05pm
8-K
vtz8t bi85
9 Feb 22
Departure of Directors or Certain Officers
4:15pm